The 17th BGICC 2025 (Breast, Gynecological and Immuno-oncology International Cancer Conference) is a premier event in the field of oncology, widely recognized as the largest and most prestigious cancer conference in both Africa and the Middle East. Scheduled to take place from January 23-24, 2025, at the Hilton Heliopolis Hotel in Cairo, Egypt, this conference serves as a hub for oncology professionals, researchers, and clinicians to gather and share cutting-edge knowledge and advancements in cancer care and treatment.
The conference will feature a comprehensive agenda that includes high-level lectures, interactive workshops, and specialized courses, providing participants with an opportunity to delve into the latest research and clinical practices in breast cancer, gynecological oncology, and immuno-oncology. The event aims to bridge the gap between scientific discovery and clinical application, offering insights into innovative therapies, emerging treatment protocols, and the evolving landscape of cancer care.
The 17th BGICC 2025 is set to be led by some of the most esteemed experts in oncology. The course will be directed by Prof. Manal El Mahdy from Ain Shams University, with Prof. Rouba Ali-Fehmi from the University of Michigan serving as the course co-director. These renowned experts will guide participants through discussions and sessions on the latest breakthroughs in cancer research and treatment.
By attending BGICC 2025, participants will not only gain valuable knowledge but also network with leaders in the oncology field, share ideas, and collaborate on global efforts to advance cancer treatment and patient care. The conference promises to be an exciting and impactful event that will shape the future of oncology in the region and beyond.
The Abstract Submission Closes at December 29th.
For Registration, visit here.
